Qinheng Zheng is an Assistant Professor of the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. Zheng received his BS from Peking University in 2014 and his PhD in chemistry from The Scripps Research Institute in 2020, where he studied the synthesis, catalysis, and functions of hexavalent sulfur fluoride compounds with Professor K. Barry Sharpless. After four years of post-doctoral training in chemical biology with Professor Kevan Shokat at UCSF, Zheng founded his lab at Harvard Medical School. The Zheng Lab uses organic chemistry, chemical biology and cancer biology to develop covalent compounds that allow chemical rescue of somatic mutations in cancer currently considered “undruggable”.
Zheng is a recipient of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists, Jake Wetchler Award for Pediatric Innovation, Robert Robinson Award in Synthetic Organic Chemistry from the Royal Society of Chemistry, and a finalist of the Reaxys PhD Prize.